Toward An Early Diagnostic Test For Ovarian Cancer
In an advance toward eventual development of a much-needed early diagnostic test for ovarian cancer, scientists have identified at least 15 biomarkers for the disease that are present in cancer patients but absent in healthy individuals. Carlito B. Lebrilla and colleagues at the University of California at Davis describe the discovery in a report scheduled for the July 7 issue of the ACS Journal of Proteome Research.
No accurate test for early diagnosis of ovarian cancer currently exists. Many of the 23,000 annual cases are diagnosed only after the disease is advanced and more difficult to treat. Lebrilla's group identified the biomarkers -- which could become the basis of a test -- with an exciting new technology spawned by the human genome project. Called glycomics, it focuses on the structure and function of chains of sugars or "oligosaccharides" that have key functions in the body.
The scientists identified and studied oligosaccharides in substances that ovarian cancer cells shed during growth. Some had never been detected before. Researchers now are moving ahead with studies involving more patients and controls in an effort to find biomarkers that could be used in an ovarian cancer test.
read more...
Monday, July 03, 2006
Wednesday, June 28, 2006
The Market With the Highest Initial Listing Standards in the World
On July 1, 2006, the NASDAQ National Market will be renamed the NASDAQ Global Market. In conjunction with this, NASDAQ will create the new NASDAQ Global Select Market, a segment of the NASDAQ Global Market with the highest initial listing standards of any exchange in the world based on financial and liquidity requirements.
"Mannatech is an example of an industry leader that has achieved superior listing standards, which clearly defines the essence of the NASDAQ Global Select Market," said NASDAQ's Bruce Aust, Executive Vice President, Corporate Client Group. "NASDAQ is focused on leading a race to the top in terms of listing qualifications. In recognizing these companies, we are highlighting their achievement in meeting the requirements to be included in the market with the highest listing standards in the world," added Mr. Aust.
Read more...
On July 1, 2006, the NASDAQ National Market will be renamed the NASDAQ Global Market. In conjunction with this, NASDAQ will create the new NASDAQ Global Select Market, a segment of the NASDAQ Global Market with the highest initial listing standards of any exchange in the world based on financial and liquidity requirements.
"Mannatech is an example of an industry leader that has achieved superior listing standards, which clearly defines the essence of the NASDAQ Global Select Market," said NASDAQ's Bruce Aust, Executive Vice President, Corporate Client Group. "NASDAQ is focused on leading a race to the top in terms of listing qualifications. In recognizing these companies, we are highlighting their achievement in meeting the requirements to be included in the market with the highest listing standards in the world," added Mr. Aust.
Read more...
Monday, June 19, 2006
Company Infringes on Patented Glyconutritional Technology
Techmedica Health Inc. has been sued for manufacturing, selling and using a glyconutritional product, under the brand name Nutratose, that violates the patented glyconutritional technology.
The glyconutrient technology is supported by substantial investment in areas such as research and development, product refinement, quality control and regulatory compliance. The company employs a growing staff of doctors, researchers, chemists and health science professionals dedicated to helping develop unique, technologically superior products.
Read more...
Techmedica Health Inc. has been sued for manufacturing, selling and using a glyconutritional product, under the brand name Nutratose, that violates the patented glyconutritional technology.
The glyconutrient technology is supported by substantial investment in areas such as research and development, product refinement, quality control and regulatory compliance. The company employs a growing staff of doctors, researchers, chemists and health science professionals dedicated to helping develop unique, technologically superior products.
Read more...
Wednesday, May 24, 2006
Increasing Awareness of Healthcare and Growing Income Levels Drive Chinese Nutraceuticals Market
Increasing interest surrounding the benefits of nutraceuticals are driving their use in China. Government policies aimed at liberalizing previous restrictions on health food sales is helping to boost demand for nutraceuticals. Frost & Sullivan(http://www.food.frost.com/) research found that the Nutraceuticals Market in China was worth $12.5 billion in 2005.
"Nutraceuticals products have been seen as being able to alleviate some of the problems caused by an unbalanced diet," states Frost & SullivanProgramme Manager Kathy Brownlie.
As consumers become more health conscious, the government too has renewed focus on improving public health. Specific examples include: the finalization of the health food registration regulations in 2005, the establishing of clear measures for the examination and administration of health food advertisements, and ongoing efforts at obtaining regulatory approval for direct sales of health foods.
Read more...
Increasing interest surrounding the benefits of nutraceuticals are driving their use in China. Government policies aimed at liberalizing previous restrictions on health food sales is helping to boost demand for nutraceuticals. Frost & Sullivan(http://www.food.frost.com/) research found that the Nutraceuticals Market in China was worth $12.5 billion in 2005.
"Nutraceuticals products have been seen as being able to alleviate some of the problems caused by an unbalanced diet," states Frost & SullivanProgramme Manager Kathy Brownlie.
As consumers become more health conscious, the government too has renewed focus on improving public health. Specific examples include: the finalization of the health food registration regulations in 2005, the establishing of clear measures for the examination and administration of health food advertisements, and ongoing efforts at obtaining regulatory approval for direct sales of health foods.
Read more...
Sunday, April 09, 2006
Glyconutrient Patent Successfully Enforced Against a Nutritional Supplements Firm Based in the United Kingdom
The patent has successfully been enforced against Bion/Elphanta, a nutritional supplements firm based in the United Kingdom. In an order filed with the High Court of Justice patents court in London, Bion agreed to stop breaching the U.K. patent on technology related to the glyconutritional blend, a unique glyconutritional formulation introduced in 1996. Bion also agreed to stop the manufacture, sales and importation of all dietary supplements related to glyconutrition "in any form and by any means."
Read more...
The patent has successfully been enforced against Bion/Elphanta, a nutritional supplements firm based in the United Kingdom. In an order filed with the High Court of Justice patents court in London, Bion agreed to stop breaching the U.K. patent on technology related to the glyconutritional blend, a unique glyconutritional formulation introduced in 1996. Bion also agreed to stop the manufacture, sales and importation of all dietary supplements related to glyconutrition "in any form and by any means."
Read more...
Subscribe to:
Posts (Atom)